Results 1 to 10 of about 2,476 (230)

High-Resolution Genetics Identifies the Lipid Transfer Protein Sec14p as Target for Antifungal Ergolines. [PDF]

open access: goldPLoS Genetics, 2016
Invasive infections by fungal pathogens cause more deaths than malaria worldwide. We found the ergoline compound NGx04 in an antifungal screen, with selectivity over mammalian cells.
Ireos Filipuzzi   +13 more
doaj   +20 more sources

Ergolines as selective 5-HT1 agonists

open access: greenJournal of Medicinal Chemistry, 1988
The synthesis and serotonin receptor subtype affinity of a series of ergolines are described. High selectivity for the 5-HT1 subtype was found with a number of 8-substituted (3 beta, 5 beta)-9,10-didehydro-6-methylergolines. The more potent and selective of these compounds increased the concentration of serotonin and decreased the concentration of 5 ...
John S. Ward   +6 more
semanticscholar   +4 more sources

Biological studies of clavine alkaloids targeting CNS receptors [PDF]

open access: yesFrontiers in Psychiatry, 2023
In contrast to well established psychedelics such as lysergic acid diethylamide (LSD) and psilocybin, ergot alkaloids of the clavine subclass have not been thoroughly investigated, in spite of their broad occurrence in nature and their well-established ...
Nikhil R. Tasker   +2 more
doaj   +2 more sources

Synthetic Strategies toward Lysergic Acid Diethylamide: Ergoline Synthesis via α-Arylation, Borrowing Hydrogen Alkylation, and C-H Insertion. [PDF]

open access: yesJ Org Chem, 2023
Lysergic acid diethylamide (LSD), a semisynthetic ergoline alkaloid analogue and hallucinogen, is a potent psychoplastogen with promising therapeutic potential.
Tuck JR, Dunlap LE, Olson DE.
europepmc   +3 more sources

Psychedelics: A new era of treatment? [PDF]

open access: yesEuropean Psychiatry, 2021
Introduction Psychedelics - including LSD (lysergic acid diethylamide), psilocybin, DMT (N, N-dimethyltryptamine), ayahuasca and mescaline - have an ancient history across various civilizations.
S. Torres
doaj   +2 more sources

Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A Receptor

open access: goldEmerging Trends in Drugs, Addictions, and Health
Introduction: Serotonergic psychedelics induce their characteristic subjective effects via activation of the serotonin 2A receptor (5-HT2AR). This structurally diverse class of drugs includes ergolines (e.g., LSD), phenethylamines (e.g., mescaline), and ...
E. Pottie   +3 more
doaj   +2 more sources

Pleuropulmonary changes induced by ergoline drugs [PDF]

open access: bronzeEuropean Respiratory Journal, 1996
Classic ergolines, such as bromocriptine, methysergide and ergotamine, can induce chronic pleuropneumonitis. We present the cases of eight patients who developed similar changes whilst on other ergolines. In this retrospective case study spanning 1985-1995, clinical data, radiological material, pulmonary function, bronchoalveolar lavage and ...
Pierre Pfitzenmeyer   +7 more
openalex   +4 more sources

Structure-Activity Relationship Analysis of Psychedelics in a Rat Model of Asthma Reveals the Anti-Inflammatory Pharmacophore. [PDF]

open access: yesACS Pharmacol Transl Sci, 2021
Psychedelic drugs can exert potent anti-inflammatory effects. However, anti-inflammatory effects do not appear to correlate with behavioral activity, suggesting different underlying mechanisms.
Flanagan TW   +5 more
europepmc   +3 more sources

5-HT<sub>2A</sub> receptors: Pharmacology and functional selectivity. [PDF]

open access: yesPharmacol Rev
Serotonin 5-HT receptors were one of the first serotonin receptors to be pharmacologically characterized. In mammals, they are expressed throughout the body in nearly every cell and tissue type, with the highest density in cortical layer V of the brain ...
Cummins BR   +3 more
europepmc   +3 more sources

Ropinirole, a Non‐Ergoline Dopamine Agonist [PDF]

open access: bronzeCNS Drug Reviews, 2005
ABSTRACTDopamine agonists have become indispensable in the treatment of Parkinson's disease. In every‐day practice, however, the decision to select the best compound for an individual patient is rendered difficult because of the large number of substances available on the market.
Wolfgang H. Jost, Dieter Angersbach
openalex   +3 more sources

Home - About - Disclaimer - Privacy